|
Rezk YA, Hurley KE, Carter J, Dao F, Bochner BH, Aubey JJ, Caceres A, Einstein MH, Abu-Rustum NR, Barakat RR, Makker V, Chi DS. A prospective study of quality of life in patients undergoing pelvic exenteration: interim results. Gynecol Oncol. 2013;128(2):191-7.
Andikyan V, Rezk Y, Einstein MH, Gualtiere G, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Barakat RR, Basch EM, Chi DS. A prospective study of the feasibility and acceptability of a web-based, electronic, patient-reported, outcome system in assessing patient recovery after major gynecologic cancer surgery. Gynecol Oncol Nov 2012;127(2):273-7.
Rezk Y, Smith H, Timmins P. Palliative care in gynecologic oncology. Am J Hosp Palliat Care 2011;28:356-74.
Rezk Y, Balulad S, Keller R, Bennett J. Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart. Am J Obstet Gynecol 2006;194:e23-6.
Rezk Y, Sheinfeld J, Chi D. Prolonged survival following salvage surgery for chemorefractory ovarian immature teratoma: a case report and a review of the literature. Gynecol Oncol 2005;96:883-7.
Rezk Y, Huff C, Rizk B. Effect of glutamine on preimplantation mouse embryo development in vitro. Am J Obstet Gynecol 2004;190:1450-5.
Abdel-Hamid H, Rezk Y, Nawar M, Formentini E, Chehata H, Abuzeid M, Rizk B. Normal pregnancy outcome after inadvertent long-term exposure to gonadotropin-releasing hormone agonist: a case report and review of the literature. MEFSJ 2002;7:237-41.
Gore L, Nawar M, Rezk Y, Chehata H, Abuzeid M, Ashraf M, Rizk B. Resistant unilateral hydrothorax as the sole manifestation of ovarian hyperstimulation syndrome: a case report and a literature review. MEFSJ 2002;7:149-53.
|
